AbbVie

AbbVie Inc. is a leading global biopharmaceutical company headquartered in North Chicago, Illinois. Established in 2013 as a spin-off from Abbott Laboratories, AbbVie focuses on developing innovative medicines across multiple therapeutic areas, inclu medicines across multiple therapeutic areas, including immunology, oncology, neuroscience, virology, gastroenterology, eye care, and aesthetics. The company is widely recognized for its blockbuster drugs such as Humira, Skyrizi, Rinvoq, Imbruvica, and Vraylar, as well as Botox, which is used for both aesthetic and medical treatments. With operations in over 175 countries and a workforce of more than 50,000 employees, AbbVie is dedicated to advancing research and delivering transformative treatments to patients worldwide. In 2020, the company expanded its portfolio through a $63 billion acquisition of Allergan, further strengthening its position in neuroscience and aesthetics. Despite increasing competition from biosimilars, AbbVie continues to invest in biologics and next-generation therapies to maintain its leadership in the pharmaceutical industry. The company is publicly traded on the New York Stock Exchange under the ticker ABBV and generates annual revenue exceeding $50 billion. ...view more